Breakthrough in age-related disease treatment
A study conducted by Sechenov Medical University in Russia and the Novosibirsk Institute of Immunological Research has revealed that immune cells begin to lose their sensitivity to inflammatory signals between the ages of 30 and 40. This discovery opens new possibilities for developing targeted preventive treatments to combat early aging-related diseases. The findings showed that aging leads to increased chronic inflammation and a decrease in cytokine receptors on immune cells, which contributes to the decline in immune response as individuals grow older.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)